Grant: CIHR-ICRH Travel Awards - General pool
University of Calgary
$1,500.00
Serum Estradiol Levels and Cardiovascular Risk Associated with Gender-Affirming Hormone use in Transgender Women: A Systematic Review and Meta-Analysis
FY 2022-23
Summary
Gender-affirming estrogen therapy (GAET) may increase cardiovascular (CV) risk in transgender women (male at birth with female gender identity). However, it is unclear if these risks are associated with GAET-resulting serum estradiol concentrations. Our objective was to determine the association between serum estradiol levels and CV-related mortality, adverse events and CV surrogate markers in transgender women.
Department
Program
CIHR-ICRH Travel Awards - General pool
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
480726
Name
Rytz Chantal
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases
Projecttitle
Serum Estradiol Levels and Cardiovascular Risk Associated with Gender-Affirming Hormone use in Transgender Women: A Systematic Review and Meta-Analysis
Programtype2
Undefined
Orgnameinp2
University of Calgary
Cihramount2
$1,500
Cihrequipment2
$0
Programname2
CIHR-ICRH Travel Awards - General pool
Keyworddelim
Cardiovascular Risk; Gender-Affirming Hormone; Systematic Review; Transgender Women
Abstract
Gender-affirming estrogen therapy (GAET) may increase cardiovascular (CV) risk in transgender women (male at birth with female gender identity). However, it is unclear if these risks are associated with GAET-resulting serum estradiol concentrations. Our objective was to determine the association between serum estradiol levels and CV-related mortality, adverse events and CV surrogate markers in transgender women.
Competitiondate
202301
Approvedterm2
1 yr 0 mth
Pinamesdelim
Rytz, Chantal
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $1,500~ $0~
